Comparison of serum inhibin A and estradiol levels for monitoring ovarian stimulation in IVF: a preliminary study.

J Gynecol Obstet Hum Reprod

Service de médecine et biologie de la reproduction, gynécologie médicale, CHU Nantes, Nantes, France; Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France.

Published: June 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: Controlled Ovarian Hyperstimulation (COH) is crucial in Assisted Reproductive Techniques (ART), as it determines the number of mature oocytes retrieved, a key factor in pregnancy success. Serum estradiol (E2) is commonly used alongside transvaginal ultrasound (TVUS) to monitor ovarian response, but its accuracy is limited due to secretion from multiple follicular categories. In contrast, serum Inhibin A, primarily secreted by mature antral follicles, may offer a more accurate reflection of follicular maturity.

Materials And Methods: This retrospective study involved women undergoing COH for in vitro fertilization (IVF) using an antagonist protocol. Serum levels of E2 and Inhibin A were measured on the day of hCG trigger. The study assessed their association with ovarian response, specifically the number of mature follicles and mature oocytes retrieved.

Results: The study included 84 IVF cycles. The total number of oocytes retrieved and the number of mature oocytes were significantly correlated with serum levels of Inhibin A (R² = 0.253 and R² = 0.267, respectively; p < 0.001) and estradiol (R² = 0.344 and R² = 0.259, respectively; p < 0.001). The correlation with Inhibin A strengthened with increasing follicular size, while the correlation with estradiol remained stable.

Conclusion: These findings suggest that serum Inhibin A, combined with transvaginal ultrasound, could help improve the timing of the hCG trigger. It may offer a more accurate assessment of follicular maturity compared to estradiol alone. Further studies are needed to confirm its role in routine IVF monitoring.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jogoh.2025.102988DOI Listing

Publication Analysis

Top Keywords

serum inhibin
12
number mature
12
mature oocytes
12
oocytes retrieved
8
transvaginal ultrasound
8
ovarian response
8
offer accurate
8
serum levels
8
levels inhibin
8
hcg trigger
8

Similar Publications

Ovarian aging is characterized by a gradual decline in both reproductive and endocrine functions, ultimately culminating in the cessation of ovarian activity around the age of 50, when most women experience natural menopause. The decline begins early, as follicular attrition is initiated in utero and continues throughout childhood and reproductive life. Most follicles undergo atresia without progressing through substantial stages of growth.

View Article and Find Full Text PDF

Background: Inhibin B (InhB) is secreted by granulosa cells and reflects early follicular activity. While anti-Müllerian hormone (AMH) and antral follicle count (AFC) are established ovarian reserve markers, the role of bioavailable inhibin B (bio-InhB) in predicting oocyte yield remains uncertain. This is particularly relevant in women with low ovarian reserve, where reliable prediction of ovarian response is clinically important.

View Article and Find Full Text PDF

Lay Summary: Creatine is a nutrient that helps provide energy to different parts of the body, including the testes. Since making sperm takes a lot of energy, creatine might play a role in supporting sperm health. Some studies suggest it could help, while others raise concerns.

View Article and Find Full Text PDF

Objective: RANKL has been suggested as a novel regulator of male reproduction and a recent RCT showed that the RANKL-inhibitor denosumab, normally used to treat osteoporosis, can improve semen quality in infertile men with high AMH and small testicles. Therefore, this RCT aimed to investigate the effect on denosumab in men with severe oligospermia prospectively selected by serum AMH and testicular size.

Materials And Methods: A double-blinded, placebo-controlled, single-center, randomized clinical trial, including 42 men with oligospermia with the main endpoint of improving sperm concentration.

View Article and Find Full Text PDF